Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
MODERNA, INC. via MODERNA, INC.
2026 · third_quarter · Q3
Vaccine Policy, FDA Vaccine Approval, mRNA Federal Policy, Oncology Innovation, Vaccines for Children Program, Patent Litigation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MODERNA, INC. via MODERNA, INC.
2026 · second_quarter · Q2
Source: Senate LDA
Vaccine Policy, FDA Vaccine Approvals
Filing targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
MODERNA, INC. via MODERNA, INC.
2026 · first_quarter · Q1
Vaccine Policy, FDA Vaccine Approvals
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MODERNA, INC. via MODERNA, INC.
2025 · third_quarter · 3A
Vaccine Policy
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
MODERNA, INC. via MODERNA, INC.
2025 · fourth_quarter · Q4
Vaccine Policy Expansion of U.S. manufacturing
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MODERNA, INC. via MODERNA, INC.
2025 · third_quarter · 3A
Vaccine Policy
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office